SAMPLE INFORMATION

Sample Name: FASE MOVIL Acquired By: Analista_1

Sample T ype: Unknown Sample Set Name: Secuencia UPLC
Vial: Acq. Method Set: Fluorouracilo Met Set UPLC
Injection #: 2, 4, 3, 5, 1 Processing Method: Met Pro 9
Injection Volume: 2.00 ul Channel Name: W2996 266nm-1.2nm
Run Time: 1.7 Minutes Proc. Chnl. Descr.: W2996 266nm-1.2nm

Date Acquired:
15/7/2019 10:42:43 ETC, 15/7/2019 10:46:15 ETC, 15/7/2019 10:49:47 ETC, 15/7/2019 10:53:19 ETC, 15/7/2019 10:56:51 ETC

Date Processed: 17/7/2019 8:43:21 ETC, 17/7/2019 8:44:06 ETC, 17/7/2019 8:44:51 ETC, 17/7/2019 8:45:36 ETC, 17/7/2019 8:46:21 ETC

Flutamida 250 mg
Lote: 19284

Peak Summary with Statistics

Name: Flutamida
Sample Retention
Vial Inj Name
Name Time (min)
1 FASE MOVIL 1: A,2 2 Flutamida 5.241
2 FASE MOVIL 1: A,3 Flutamida
4 5.238
3 FASE MOVIL 1: A,4 Flutamida
3 5.240
4 FASE MOVIL 1: A,5 Flutamida
5 5.241
5 FASE MOVIL 1: A,6 Flutamida
1 5.241
Mean 5.240
Std. Dev. 0.001
% RSD 0.03

Reported by User: Analista_1 Project Name: Análisis de Ptoductos/Flutamida

Report Method: M MP Date Printed:
Report Method ID: 2051 17/07/19
Page: 1 of 1 8:47:04 America/Guayaquil